Andrew Kenneth William Powell, Director at Aclaris Therapeutics, Inc. (ACRS), bought 14,500 shares at $1.25 ($18K) on 2024-03-04, disclosed to the SEC on 2024-03-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.23 | 8,500 | $10K | 58.2% |
| 2 | $1.25 | 6,000 | $8K | 41.8% |
| Total | $1.24 avg | 14,500 | $18K | 100% |
| Filing → |
| MDVN | SELL | 2016-06-06 | $312K | — | Filing → |
| ITMN | SELL | 2014-09-03 | $551K | — | Filing → |
| ITMN | SELL | 2014-06-03 | $39K | — | Filing → |